ArticleJournal of pediatric gastroenterology and nutrition2026
The incidence and prevalence of paediatric inflammatory bowel disease in Scotland: A nationwide study from 2015 to 2018.
Article in Journal of pediatric gastroenterology and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The incidence and prevalence of paediatric inflammatory bowel disease in Scotland: A nationwide study from 2015 to 2018.Journal of pediatric gastroenterology and nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesScotland is known to have the highest incidence of paediatric-onset inflammatory bowel disease (PIBD) in the United Kingdom and one of the highest worldwide; however, data on prevalence is lacking. We aimed to calculate the PIBD incidence and prevalence rates in Scotland during 2015 to 2018.
methodsIncident and prevalent cases of PIBD were prospectively recorded by the three Scottish regional paediatric gastroenterology networks covering all paediatric units nationwide. PIBD was defined as children <16 years of age with Crohn's disease, ulcerative colitis or inflammatory bowel disease type unclassified. The incidence rate for the period from 2015 to 2018, the point prevalence (30th June each year) and the period prevalence (calendar year) were each calculated using publicly accessible Scottish population data.
resultsIn total, 438 patients were diagnosed with PIBD in Scotland over the 4-year study period, providing an overall incidence rate of 12.0/100,000 person-years. The number of prevalent patients per year ranged from 518 to 538, with the highest period prevalence 58.5/100,000 person-years (01 January 2016-31 December 2016) and the highest point prevalence 45.9/100,000 persons (30 June 17). One hundred and fifty-nine patients ≥16 years of age remained within paediatric services in 2017; differences in transition practices were observed across regions.
conclusionsThe Scottish PIBD incidence and prevalence remain the highest reported in nationwide studies worldwide (aged < 16 years). The high prevalence is in keeping with the high incidence rate and minimal mortality rate, so continues to rise. The true caseload within paediatric services, including patients ≥16 years of age, may be up to 30% higher.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.